DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.

Saved in:
Bibliographic Details
Main Authors CHU, Yu-Waye, RAMANUJAN, Saroja, GADKAR, Kapil, LI, Chi-Chung, HOSSEINI, Iraj
Format Patent
LanguageEnglish
French
German
Published 25.09.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.
AbstractList The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.
Author CHU, Yu-Waye
GADKAR, Kapil
HOSSEINI, Iraj
LI, Chi-Chung
RAMANUJAN, Saroja
Author_xml – fullname: CHU, Yu-Waye
– fullname: RAMANUJAN, Saroja
– fullname: GADKAR, Kapil
– fullname: LI, Chi-Chung
– fullname: HOSSEINI, Iraj
BookMark eNrjYmDJy89L5WRwcvEP9vRzV3DzD1IICXJ1DPF19QtRCPcM8VBw9Avx1HV2MTLQh7KMFZw8gwNcnT3dPJ3Bsk7-Lp6uwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNjUxNDCxNjR0JgIJQCMdiwZ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DOSIERUNG ZUR BEHANDLUNG MIT ANTI-CD20/ANTI-CD3-BISPEZIFISCHEN ANTIKÖRPERN
DOSAGE POUR LE TRAITEMENT AVEC DES ANTICORPS BISPÉCIFIQUES ANTI-CD20/ANTI-CD3
ExternalDocumentID EP3541843A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3541843A13
IEDL.DBID EVB
IngestDate Fri Aug 16 05:48:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3541843A13
Notes Application Number: EP20170808689
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190925&DB=EPODOC&CC=EP&NR=3541843A1
ParticipantIDs epo_espacenet_EP3541843A1
PublicationCentury 2000
PublicationDate 20190925
PublicationDateYYYYMMDD 2019-09-25
PublicationDate_xml – month: 09
  year: 2019
  text: 20190925
  day: 25
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Genentech, Inc
RelatedCompanies_xml – name: Genentech, Inc
Score 3.233091
Snippet The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190925&DB=EPODOC&locale=&CC=EP&NR=3541843A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LToNAcNJUo960aqyv7MFwI0VgKT0QAwsIJgXSovbWLGWb9EIbi_H3nSW0etHbZCeZzE4yr915ADwsqc0NrqF-60JTzaHB1YKWmlroYoEA-nxLNjiPEyt6NV9mdNaB1a4XppkT-tUMR0SNWqC-14293vw8YvlNbeV2UKzwaP0U5o6vtNkxereRThXfc4Is9VOmMIaQkkwcg5pys4mLidKBjKLlmP3gzZNNKZvfHiU8hcMMiVX1GXRE1YNjtlu81oOjcfvfjWCrettz8Px0GifPBLM2kk8CN5dT-Ml7nEfETfJYZb6uDVrIIF48zQIWhzFrsF4qw74LIGGQs0hFZub7i8-DbM-2cQndal2JKyDLwkQD-1iWZilMrhe8tC3MW6jBRzYX9qIP_T_JXP-Du4ETKUFZDKHTW-jWH5_iDj1uXdw3svoG-pR_rw
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSP42oPpraH2AeVADN22dhXaBqpyI1u6JFwKkRr_vrNNQS96m-wmk9lJZma_3XkA3C8tmxtcQ_vWhaaaPYOrqZVpaqqLBRIY87uywHkcdoNX83lmzWqw2tXClH1Cv8rmiGhRC7T3ovTXm59HLLfMrdx20hUurR_9ZOAqFTrG6NbXLcV1Bl4cuRFVKEVKCScDwzLlZJMhAqWDHiJC2Wbfe3NkUcrmd0TxT-AwRmZ5cQo1kTehQXeD15pwNK7-u5GsTG97Bo4bTVn4RBC1kWTiDRPZhZ-8syQgwzBhKnV1rVNRBnHYNPYo8xktd51IXvvOgfheQgMVhZnvDz734r3YxgXU83UuLoEsUxMd7EOWmZkwuZ7yzO4ibrEM3re5sBctaP3Jpv3P3h00gmQ8mo9Y-HIFx1KbMjFCt66hXnx8ihuMvkV6W-rtGxi8gpo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOSING+FOR+TREATMENT+WITH+ANTI-CD20%2FANTI-CD3+BISPECIFIC+ANTIBODIES&rft.inventor=CHU%2C+Yu-Waye&rft.inventor=RAMANUJAN%2C+Saroja&rft.inventor=GADKAR%2C+Kapil&rft.inventor=LI%2C+Chi-Chung&rft.inventor=HOSSEINI%2C+Iraj&rft.date=2019-09-25&rft.externalDBID=A1&rft.externalDocID=EP3541843A1